Together with less-studio, NanoEcho has developed a modern and intuitive user interface, which is now being implemented in NanoEcho’s imaging system prior to commercialization.
Developing a user-friendly interface is an important part of the commercial and regulatory work. The goal is to provide users with an intuitive experience; NanoEcho’s imaging system must be clear and easy to use and in additional it must meet the regulatory requirements for a medical device.
The NanoEcho interface has been developed together with less-studio, specialized in developing user interfaces. Implementation has now started to prepare the system for the upcoming formal verification process.
“To succeed in the market, it is important to offer a system that is intuitive. Many traditional systems in image diagnostics require a lot of training and experience from the user, and we have deliberately worked to reduce this. We are very satisfied with the result of the collaboration with less-studio, which has solid specialist competence in modern user interaction. Now we look forward to the implementation of the user interface,” says Linda Persson CEO of NanoEcho.
“With our experience from well-known global companies and digital products, we have created an interface that feels new, modern and easy to use, which makes the job easier and faster during the clinical examination”, says Mick Cordero CEO at less-studio.
For further information, please contact:
Kristina Hallström, CMO & CCO
email: ir@nanoecho.se
NanoEcho develops a new technology for clearer diagnostics of, in the first indication, rectal cancer. The imaging technology is based on a new medical approach where nanotechnology is used in combination with modern patented ultrasound technology. The images that are generated are intended to facilitate differentiation between healthy and diseased tissue and at the same time determine the location of the cancer tissue more precisely. The aim is to provide more precise, simple, and cost-effective diagnosis of cancers and other diseases. With clearer diagnostics, the company wants to assist treating physicians with better guidance for more personalised treatment. Both the quality of life of the patients and their chance of survival can improve after treatment, with reduced treatment costs. www.nanoecho.se
Image Attachments
Image of NanoEcho’s interface